Recursion Pharmaceuticals
RXRX
RXRX
192 hedge funds and large institutions have $1.16B invested in Recursion Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 56 funds opening new positions, 74 increasing their positions, 38 reducing their positions, and 20 closing their positions.
Holders
192
Holders Change
+34
Holders Change %
+21.52%
% of All Funds
3.06%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.08%
New
56
Increased
74
Reduced
38
Closed
20
Calls
$5.88M
Puts
$6.09M
Net Calls
-$206K
Net Calls Change
-$478K
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
201
HSBC Holdings
London,
United Kingdom
| – | -$148K | -19,495 | Closed |
|
|
FRM
202
Fox Run Management
Greenwich,
Connecticut
| – | -$141K | -18,917 | Closed |
|
|
VIA
203
Vident Investment Advisory
Alpharetta,
Georgia
| – | -$133K | -17,849 | Closed |
|
|
CF
204
Centaurus Financial
Anaheim,
California
| – | -$99K | -13,242 | Closed |
|
|
HF
205
HRT Financial
New York
| – | -$91K | -12,314 | Closed |
|
|
AWM
206
Accel Wealth Management
Waverly,
Iowa
| – | -$77.2K | -10,330 | Closed |
|
|
DU
207
Delphia (USA)
Toronto,
Ontario, Canada
| – | -$76.3K | -10,212 | Closed |
|
|
ODG
208
O'Dell Group
Cincinnati,
Ohio
| – | -$8.78K | -1,175 | Closed |
|
|
CIA
209
Cape Investment Advisory
Mcdonough,
Georgia
| – | -$1.87K | -250 | Closed |
|
210
US Bancorp
Minneapolis,
Minnesota
| – | -$859 | -115 | Closed |
|